All Stories

  1. Polycystic Ovary Syndrome, Combined Oral Contraceptives, and the Risk of Dysglycemia: A Population-Based Cohort Study With a Nested Pharmacoepidemiological Case-Control Study

    Article • Diabetes Care, October 2021, American Diabetes Association

    Prof Wiebke Arlt

  2. Mitotane treatment in patients with metastatic testicular Leydig cell tumor associated with severe androgen excess

    Article • European Journal of Endocrinology, January 2018, Bioscientifica

    Prof Wiebke Arlt

  3. AKR1C3-Mediated Adipose Androgen Generation Drives Lipotoxicity in Women With Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2017, Endocrine Society

    Prof Wiebke Arlt

  4. Outcome of Nonfunctioning Pituitary Adenomas That Regrow After Primary Treatment: A Study From Two Large UK Centers

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2017, Endocrine Society

    Dr. Michael W O'Reilly, Dr Niki Karavitaki, Prof Wiebke Arlt, GEORGIA NTALI, ashley grossman

  5. The Steroid Metabolome in the Isolated Ovarian Follicle and Its Response to Androgen Exposure and Antagonism

    Article • Endocrinology, February 2017, Endocrine Society

    Prof Wiebke Arlt, Jenny Visser

  6. Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality

    Article • European Journal of Endocrinology, February 2017, Bioscientifica

    Prof Wiebke Arlt

  7. The effect of high cortisol levels on fat tissue function

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2017, Endocrine Society

    Dr. Michael W O'Reilly, Prof Wiebke Arlt, Dr Konstantinos Manolopoulos

  8. Bilateral testicular tumors resulting in recurrent Cushing’s syndrome after bilateral adrenalectomy”

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2016, Endocrine Society

    Prof Wiebke Arlt

  9. 11-oxygenated C19 steroids are the predominant androgens in polycystic ovary syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2016, Endocrine Society

    Prof Wiebke Arlt, Dr Punith Kempegowda, Dr. Michael W O'Reilly

  10. Modified release and conventional glucocorticoids and diurnal androgen excretion in congenital adrenal hyperplasia

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2016, Endocrine Society

    Nils Krone, Prof Wiebke Arlt, Martin Whitaker

  11. SOCIETY FOR ENDOCRINOLOGY ENDOCRINE EMERGENCY GUIDANCE: Emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients

    Article • Endocrine Connections, September 2016, Bioscientifica

    Prof Wiebke Arlt

  12. Imaging is too unspecific to reliably differentiate benign from malignant adrenal tumours.

    Article • European Journal of Endocrinology, June 2016, Bioscientifica

    Prof Wiebke Arlt

  13. PAPSS2 Deficiency Causes Androgen Excess via Impaired DHEA Sulfation—In Vitro and in Vivo Studies in a Family Harboring Two Novel PAPSS2 Mutations

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2015, Endocrine Society

    Prof Wiebke Arlt

  14. Hyperandrogenemia Predicts Metabolic Phenotype in Polycystic Ovary Syndrome: The Utility of Serum Androstenedione

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2014, Endocrine Society

    Prof Wiebke Arlt

  15. Mitotane Therapy in Adrenocortical Cancer Induces CYP3A4 and Inhibits 5α-Reductase, Explaining the Need for Personalized Glucocorticoid and Androgen Replacement

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2013, Endocrine Society

    Dr Niki Karavitaki, Prof Wiebke Arlt

  16. Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2012, Endocrine Society

    Prof Wiebke Arlt

  17. Urine Steroid Metabolomics as a Biomarker Tool for Detecting Malignancy in Adrenal Tumors

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2011, Endocrine Society

    Prof Wiebke Arlt

  18. Sex Steroid Metabolism in Human Peripheral Blood Mononuclear Cells Changes with Aging

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2005, Endocrine Society

    Prof Wiebke Arlt

  19. No Evidence for Hepatic Conversion of Dehydroepiandrosterone (DHEA) Sulfate to DHEA:In Vivoandin VitroStudies

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2005, Endocrine Society

    Prof Wiebke Arlt

  20. DHEA Replacement in Adrenal Insufficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2003, Endocrine Society

    Prof Wiebke Arlt

  21. Beyond Adrenal and Ovarian Androgen Generation: Increased Peripheral 5α-Reductase Activity in Women with Polycystic Ovary Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2003, Endocrine Society

    Prof Wiebke Arlt